Accelerate COVID-19 research with SimpleStep ELISAs

Accelerate COVID-19 research with SimpleStep ELISAs

Molecular Diagnostics / Molecular Biology

July 16, 2021

Abcam’s SimpleStep ELISA assays for key targets in COVID-19 have been extensively validated to support you in coronavirus research by ensuring quick and reproducible results.
​Fast, reproducible results are essential to all aspects of coronavirus research. Abcam’s broad range of SimpleStep ELISAs offers validated assays for key targets in COVID-19, including receptors, cytokines, cell signaling proteins, and adherence proteins.
Click here to learn more!

New CFTR MASTR Dx validated for dried blood spots

New CFTR MASTR Dx validated for dried blood spots

Molecular Diagnostics / Molecular Biology

Multiplicom is pleased to announce that CFTR MASTR™ Dx has been successfully validated for an additional sample type: dried blood spots. The CE-IVD claim is now extended to include DNA extracted from dried blood spots, allowing you to use the assay for routine neonatal screening.

March 12, 2015 More +
Chronic Lymphocytic Leukemia CLL Product release

Chronic Lymphocytic Leukemia CLL Product release

Molecular Diagnostics / Molecular Biology

Multiplicom is pleased to announce the release of the new CLL MASTR Plus, a RUO assay for identification of mutations in the coding regions of 9 genes related to CLL.

June 03, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us